Multivitamin therapy for recurrent aphthous stomatitis: A randomized, double-masked, placebo-controlled trial

Rajesh V. Lalla, Linda E. Choquette, Richard S. Feinn, Harriet Zawistowski, Marie C. Latortue, Edward T. Kelly, Lorena Baccaglini

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Recurrent aphthous stomatitis (RAS) is a painful condition of unknown etiology, affecting more than 2.5 billion people worldwide. Vitamin deficiencies have been implicated as a possible cause. Methods: The authors conducted a single-center, randomized, parallel-arm, double-masked, placebo-controlled study to examine the effect of daily multivitamin supplementation on the number and duration of RAS episodes. The authors randomly assigned 160 adults who had a validated history of at least three episodes of idiopathic minor RAS within the previous 12 months to one of two groups: the first group (n = 83) received a once-daily multivitamin containing 100 percent of the U.S. reference daily intake (RDI) of essential vitamins, and the second group (n = 77) received oncedaily placebo for up to 365 days. Results: The results showed no significant difference in the mean number of new RAS episodes between the multivitamin (4.19 episodes) and placebo (4.60 episodes) arms during the study period (P =.69). The mean duration of new RAS episodes also was similar for the multivitamin (8.66 days) and placebo (8.99 days) arms (P =.60). Furthermore, the authors found no differences between the two arms with regard to mouth pain, normalcy of diet or compliance with the study medication regimen. Conclusion: Daily multivitamin supplementation, with the RDI of essential vitamins, did not result in a reduction in the number or duration of RAS episodes. Clinical Implications: Clinicians should not recommend multivitamin supplementation routinely as prophylaxis for RAS.

Original languageEnglish (US)
Pages (from-to)370-376
Number of pages7
JournalJournal of the American Dental Association
Volume143
Issue number4
DOIs
StatePublished - Apr 2012

Fingerprint

Placebos
Arm
Recommended Dietary Allowances
Vitamins
Therapeutics
Avitaminosis
Sutton disease 2
Mouth
Diet
Pain

Keywords

  • Canker sore
  • Multivitamin
  • Recurrent aphthous stomatitis
  • Vitamin

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Multivitamin therapy for recurrent aphthous stomatitis : A randomized, double-masked, placebo-controlled trial. / Lalla, Rajesh V.; Choquette, Linda E.; Feinn, Richard S.; Zawistowski, Harriet; Latortue, Marie C.; Kelly, Edward T.; Baccaglini, Lorena.

In: Journal of the American Dental Association, Vol. 143, No. 4, 04.2012, p. 370-376.

Research output: Contribution to journalArticle

Lalla, Rajesh V. ; Choquette, Linda E. ; Feinn, Richard S. ; Zawistowski, Harriet ; Latortue, Marie C. ; Kelly, Edward T. ; Baccaglini, Lorena. / Multivitamin therapy for recurrent aphthous stomatitis : A randomized, double-masked, placebo-controlled trial. In: Journal of the American Dental Association. 2012 ; Vol. 143, No. 4. pp. 370-376.
@article{65e4f940c7a6426c969ce9e513053a88,
title = "Multivitamin therapy for recurrent aphthous stomatitis: A randomized, double-masked, placebo-controlled trial",
abstract = "Background: Recurrent aphthous stomatitis (RAS) is a painful condition of unknown etiology, affecting more than 2.5 billion people worldwide. Vitamin deficiencies have been implicated as a possible cause. Methods: The authors conducted a single-center, randomized, parallel-arm, double-masked, placebo-controlled study to examine the effect of daily multivitamin supplementation on the number and duration of RAS episodes. The authors randomly assigned 160 adults who had a validated history of at least three episodes of idiopathic minor RAS within the previous 12 months to one of two groups: the first group (n = 83) received a once-daily multivitamin containing 100 percent of the U.S. reference daily intake (RDI) of essential vitamins, and the second group (n = 77) received oncedaily placebo for up to 365 days. Results: The results showed no significant difference in the mean number of new RAS episodes between the multivitamin (4.19 episodes) and placebo (4.60 episodes) arms during the study period (P =.69). The mean duration of new RAS episodes also was similar for the multivitamin (8.66 days) and placebo (8.99 days) arms (P =.60). Furthermore, the authors found no differences between the two arms with regard to mouth pain, normalcy of diet or compliance with the study medication regimen. Conclusion: Daily multivitamin supplementation, with the RDI of essential vitamins, did not result in a reduction in the number or duration of RAS episodes. Clinical Implications: Clinicians should not recommend multivitamin supplementation routinely as prophylaxis for RAS.",
keywords = "Canker sore, Multivitamin, Recurrent aphthous stomatitis, Vitamin",
author = "Lalla, {Rajesh V.} and Choquette, {Linda E.} and Feinn, {Richard S.} and Harriet Zawistowski and Latortue, {Marie C.} and Kelly, {Edward T.} and Lorena Baccaglini",
year = "2012",
month = "4",
doi = "10.14219/jada.archive.2012.0179",
language = "English (US)",
volume = "143",
pages = "370--376",
journal = "Journal of the American Dental Association",
issn = "0002-8177",
publisher = "American Dental Association",
number = "4",

}

TY - JOUR

T1 - Multivitamin therapy for recurrent aphthous stomatitis

T2 - A randomized, double-masked, placebo-controlled trial

AU - Lalla, Rajesh V.

AU - Choquette, Linda E.

AU - Feinn, Richard S.

AU - Zawistowski, Harriet

AU - Latortue, Marie C.

AU - Kelly, Edward T.

AU - Baccaglini, Lorena

PY - 2012/4

Y1 - 2012/4

N2 - Background: Recurrent aphthous stomatitis (RAS) is a painful condition of unknown etiology, affecting more than 2.5 billion people worldwide. Vitamin deficiencies have been implicated as a possible cause. Methods: The authors conducted a single-center, randomized, parallel-arm, double-masked, placebo-controlled study to examine the effect of daily multivitamin supplementation on the number and duration of RAS episodes. The authors randomly assigned 160 adults who had a validated history of at least three episodes of idiopathic minor RAS within the previous 12 months to one of two groups: the first group (n = 83) received a once-daily multivitamin containing 100 percent of the U.S. reference daily intake (RDI) of essential vitamins, and the second group (n = 77) received oncedaily placebo for up to 365 days. Results: The results showed no significant difference in the mean number of new RAS episodes between the multivitamin (4.19 episodes) and placebo (4.60 episodes) arms during the study period (P =.69). The mean duration of new RAS episodes also was similar for the multivitamin (8.66 days) and placebo (8.99 days) arms (P =.60). Furthermore, the authors found no differences between the two arms with regard to mouth pain, normalcy of diet or compliance with the study medication regimen. Conclusion: Daily multivitamin supplementation, with the RDI of essential vitamins, did not result in a reduction in the number or duration of RAS episodes. Clinical Implications: Clinicians should not recommend multivitamin supplementation routinely as prophylaxis for RAS.

AB - Background: Recurrent aphthous stomatitis (RAS) is a painful condition of unknown etiology, affecting more than 2.5 billion people worldwide. Vitamin deficiencies have been implicated as a possible cause. Methods: The authors conducted a single-center, randomized, parallel-arm, double-masked, placebo-controlled study to examine the effect of daily multivitamin supplementation on the number and duration of RAS episodes. The authors randomly assigned 160 adults who had a validated history of at least three episodes of idiopathic minor RAS within the previous 12 months to one of two groups: the first group (n = 83) received a once-daily multivitamin containing 100 percent of the U.S. reference daily intake (RDI) of essential vitamins, and the second group (n = 77) received oncedaily placebo for up to 365 days. Results: The results showed no significant difference in the mean number of new RAS episodes between the multivitamin (4.19 episodes) and placebo (4.60 episodes) arms during the study period (P =.69). The mean duration of new RAS episodes also was similar for the multivitamin (8.66 days) and placebo (8.99 days) arms (P =.60). Furthermore, the authors found no differences between the two arms with regard to mouth pain, normalcy of diet or compliance with the study medication regimen. Conclusion: Daily multivitamin supplementation, with the RDI of essential vitamins, did not result in a reduction in the number or duration of RAS episodes. Clinical Implications: Clinicians should not recommend multivitamin supplementation routinely as prophylaxis for RAS.

KW - Canker sore

KW - Multivitamin

KW - Recurrent aphthous stomatitis

KW - Vitamin

UR - http://www.scopus.com/inward/record.url?scp=84860436220&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860436220&partnerID=8YFLogxK

U2 - 10.14219/jada.archive.2012.0179

DO - 10.14219/jada.archive.2012.0179

M3 - Article

C2 - 22467697

AN - SCOPUS:84860436220

VL - 143

SP - 370

EP - 376

JO - Journal of the American Dental Association

JF - Journal of the American Dental Association

SN - 0002-8177

IS - 4

ER -